Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Free Report) have received an average recommendation of “Moderate Buy” from the eleven ratings firms that are covering the company, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have issued a hold rating, seven have issued a buy rating […]

Shares of Vera Therapeutics, Inc. (NASDAQ:VERA – Get Free Report) have earned a consensus rating of “Moderate Buy” from the thirteen analysts that are covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and eleven have given a buy recommendation to the […]

Axcelis Technologies, Inc. (NASDAQ:ACLS – Get Free Report) has been assigned a consensus recommendation of “Hold” from the six brokerages that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the […]

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the eleven ratings firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, one has given a hold rating, eight have given a buy rating and […]

Wealthfront (NASDAQ:WLTH – Get Free Report) has earned an average recommendation of “Hold” from the nine brokerages that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and four have assigned a buy rating to the company. The average […]

Atlas Technical Consultants, Inc. (NASDAQ:ATCX – Get Free Report) has received an average recommendation of “Hold” from the five research firms that are presently covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating on the […]

Shares of AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) have been assigned an average rating of “Moderate Buy” from the thirteen research firms that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and ten have issued a buy recommendation on […]

Nebius Group N.V. (NASDAQ:NBIS – Get Free Report) has received a consensus rating of “Moderate Buy” from the fifteen analysts that are presently covering the company, Marketbeat reports. Six investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average twelve-month price objective among […]